Bifidobacterium and Methylphenidate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Bifidobacterium (bifidobacteria) and Methylphenidate (methylphenidate). Common drug interactions include hypertension among females and asthenia among males.

The phase IV clinical study analyzes what interactions people have when they take Bifidobacterium and Methylphenidate. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Bifidobacterium?

Bifidobacterium has active ingredients of bifidobacteria. eHealthMe is studying from 5,013 Bifidobacterium users. Check the latest studies of Bifidobacterium.

What is Methylphenidate?

Methylphenidate has active ingredients of methylphenidate. eHealthMe is studying from 8,216 Methylphenidate users. Check the latest studies of Methylphenidate.

On Jul, 11, 2026

13 people who take Bifidobacterium and Methylphenidate together, and have interactions are studied.

Bifidobacterium and Methylphenidate drug interactions.

What are the common drug interactions of Bifidobacterium and Methylphenidate, by gender? *:

female:

Hypertension (high blood pressure)
Injection site erythema (redness at injection site)
Urticaria (rash of round, red welts on the skin that itch intensely)
Decreased appetite
Dysphonia (speech disorder attributable to a disorder of phonation)
Headache (pain in head)
Insomnia (sleeplessness)
Palpitations (feelings or sensations that your heart is pounding or racing)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Anxiety

male:

Asthenia (weakness)
Fatigue (feeling of tiredness)
Malaise (a feeling of general discomfort or uneasiness)
Middle insomnia (difficulty returning to sleep after awakening either in the middle of the night)
Neuralgia (pain in one or more nerves)
Pyrexia (fever)
Sinusitis (inflammation of sinus)
Skin ulcer
Upper respiratory tract infection
Vasculitis (inflammation of a blood vessel or blood vessels)

What are the common drug interactions of Bifidobacterium and Methylphenidate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Asthma

10-19:

n/a

20-29:

n/a

30-39:

Decreased appetite
Dysphonia (speech disorder attributable to a disorder of phonation)
Headache (pain in head)
Hypertension (high blood pressure)
Insomnia (sleeplessness)
Palpitations (feelings or sensations that your heart is pounding or racing)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

40-49:

n/a

50-59:

Aphonia (inability to produce voice)
Asthenia (weakness)
Back disorder
Fatigue (feeling of tiredness)
Heart valve incompetence (heart's valves do not work correctly)
Infection
Infusion site bruising
Insomnia (sleeplessness)
Laryngitis (inflammation of the larynx)
Malaise (a feeling of general discomfort or uneasiness)

60+:

Fatigue (feeling of tiredness)
Arthralgia (joint pain)
Pain
Pneumonia
Pruritus (severe itching of the skin)
Asthenia (weakness)
Cough
Decreased appetite
Flank pain (a distressing sensation experienced around the lower back and the upper abdomen)
Injection site erythema (redness at injection site)

What are the existing conditions these people have? *

Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 30.77%
Cataplexy (loss of muscle tone accompanied by full conscious awareness): 4 people, 30.77%
Primary Immunodeficiency Syndrome: 3 people, 23.08%
Constipation: 2 people, 15.38%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 7.69%
Interstitial Lung Disease: 1 person, 7.69%
Immunodeficiency Common Variable: 1 person, 7.69%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 1 person, 7.69%
Drowsiness: 1 person, 7.69%
Asthma: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Bifidobacterium and Methylphenidate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously